Information Provided By: 
Fly News Breaks for February 15, 2018
ZTS
Feb 15, 2018 | 14:44 EDT
BofA/Merrill analyst Derik de Bruin raised Zoetis' price target to $87 from $80 and increased estimates following the Q4 beat citing operational strength and foreign exchange. The analyst sees further upside from new product launches and capital deployment and reiterated his Buy rating on Zoetis shares.
News For ZTS From the Last 2 Days
ZTS
Apr 23, 2024 | 05:05 EDT
Barclays lowered the firm's price target on Zoetis to $230 from $260 and keeps an Overweight rating on the shares ahead of the Q1 report. The analyst expects the Q1 reports to provide continuing evidence of improvement in generics and biosimilars for the specialty pharmaceuticals group.
